skip to Main Content


The Division of Surgical Oncology at BWH is comprised of 11 outstanding surgical oncologists providing comprehensive cancer care for patients with benign and malignant endocrine conditions, liver, pancreas, biliary, and stomach cancers, neuroendocrine tumors, soft tissue sarcoma, and cutaneous malignancies. Under the leadership of Division Chief and internationally recognized sarcoma surgeon Chandrajit P. Raut, MD, MSc and Department Chair and world-renowned endocrine surgeon Gerard M. Doherty, MD, the Division of Surgical Oncology is dedicated to providing the best quality cancer care to our patients through constant innovation and cutting-edge research. The division faculty have been principal investigators of many high impact studies and thought leaders behind many practice-changing policies. Monica Bertagnolli, MD, Past President of the American Society of Clinical Oncology and former Division Chief, has pioneered state of the art clinical trials across the United States as Group Chair of the Alliance for Clinical Trials in Oncology. Internationally renowned endocrine surgeon, writer, and public health researcher Atul Gawande, MD, MPH, leads Ariadne Labs, a joint center for health systems innovation, and Lifebox, a nonprofit organization dedicated to improving surgical safety globally.


Our division has championed a vast array of basic science, clinical, and health services research endeavors. Identifying important clinically, relevant research questions, faculty have studied novel solutions in the laboratory or through clinical research and evaluated and confirmed the innovative findings though clinical practice. This in turn has generated newer questions for further study. This bedside-to-bench-to-bedside cycle is a spiral escalation process. Completion of each of this cycle provides essential opportunity for safer surgery, better quality of clinical care, improved quality of life and longer survival benefit for cancer patients. Our surgical oncologists constantly challenge the most difficult clinical problems and advance the cancer field forward through such dedicated research efforts.

Back To Top